| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.78 | 0.002 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.006 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |